The member referred to elements of the Pharmac review. What the Pharmac review actually said is that the Ministry of Health should take responsibility for some medicines strategies, particularly in relation to rare disorders, because what they were saying was that Pharmac, as a procurement agency, should not be the sole arbiter of what a medicines strategy should be. And that is the recommendation we've accepted, as I've announced today, and we will do that.